Do You Really Need a Pap Smear? A Straight Guide for Women in Mumbai

The three options from 30 to 65

Once you hit 30, the guidelines converge on a menu with three items. You can have a Pap smear alone every three years. You can have a primary HPV test alone every five years. Or you can have both together, called co-testing, every five years. The USPSTF treats all three as equal choices. The ACS prefers the HPV test alone, calling it more accurate and reliable, and describes co-testing as only slightly more sensitive while doubling the test burden and turning up low-risk minor changes.

Either way, the interval stretches to five years when the HPV test is involved, because a negative HPV result rules out disease well enough that you do not need to come back sooner. And a detail that surprises many women: guidelines apply regardless of sexual history and regardless of vaccination status. That is explicit in both the ACS and USPSTF statements.

A word on what is actually available where. India's national programme uses VIA, visual inspection with acetic acid, because it needs no laboratory and works at primary health centres. In a city like Mumbai, you will more commonly be offered cytology (the Pap) or HPV DNA testing, both of which need a proper lab. WHO's 2021 position is that countries should move toward HPV DNA as the primary screening test where it is available. That is the direction things are going, and it is why many Mumbai doctors now offer the HPV test alongside or instead of the Pap for women over 30.

When screening can stop

Screening is not forever. The ACS says you can stop after 65 if your record shows adequate prior screening: two consecutive negative HPV tests, or two negative co-tests, or three negative Paps, all within the past ten years, with the most recent test inside its recommended interval. If your history is patchy or undocumented, keep screening until those criteria are met. And if your cervix was removed by hysterectomy and you never had cervical cancer or high-grade precancer, you do not need screening at all. That applies to surgery done for non-cancer reasons like fibroids. If part of the cervix was left in place, screening continues.

What the appointment is actually like

Patients ask us at the counter, more often than anything else, whether it will hurt. The honest answer from every authoritative source: it usually does not hurt. Mayo Clinic says exactly that. Cleveland Clinic says it should not hurt but may feel uncomfortable. There can be a sensation of pressure and some cramping when the speculum holds the vaginal walls apart, and light spotting afterward is normal.

The collection itself takes a few minutes. You will change into a gown and lie on an examination table, usually with your knees bent and feet in stirrups or resting apart, the standard position for any pelvic exam. The clinician narrates as they go, at least a good one does, because the unknown is worse than the sensation. With a speculum in place, the clinician uses a soft brush and a small spatula to gather cells from the outer cervix and from inside the cervical canal. The brush feels like a firm swab, not a scrape. That is the conventional Pap: cells are spread directly onto a glass slide. With liquid-based cytology, the modern method, the brush goes into a vial of preservative liquid instead. The lab spins the sample, separates out blood and mucus, and deposits the cells in a neat circle on the slide. The evidence on accuracy is genuinely mixed: some studies show slightly higher sensitivity with the liquid method, others slightly lower specificity, and one study favoured conventional. Two advantages of liquid-based cytology are not disputed: the same vial can be used for an HPV test, and the rate of unsatisfactory samples, samples too poor to read, tends to be lower. Nothing about the cost advantage, though, liquid-based tests cost more, and no study has shown either method reduces deaths compared to the other.

A practical note for Mumbai: this is not a doorstep blood draw. The sample needs a speculum exam by a clinician, so home collection, which we do for most blood tests, does not apply here. Book a visit, and the rest of the process, reporting and all, works like any other test.

The 48 hours before: what actually matters for a clean sample

The preparation rules are short, and they exist for one reason: anything that disturbs the cells or coats the cervix can ruin the sample. Mayo Clinic, the CDC, and Cleveland Clinic agree on the core list. For two full days before the test, avoid vaginal intercourse, douching, vaginal medicines, and spermicidal foams, creams, or jellies. Tell the clinician about a latex allergy, any bleeding disorder or blood thinner, the possibility of pregnancy, and the date of your last period.

On menstruation, the sources split slightly, and the split is worth stating plainly. Mayo Clinic advises trying not to schedule the test during your period, while the CDC says both the Pap and HPV tests can still be done if your period arrives, and not to cancel, just mention it. The truth both agree on: a period is not an absolute barrier, it is a question of sample quality. Heavy flow on day one or two is the worst timing; light spotting is less of a problem. If your bleeding is not part of your regular period, do not delay the test at all.

One more thing the CDC is blunt about: if you did have intercourse before the appointment, do not skip it. Go anyway and tell the doctor.

Your questions, answered

Does a Pap smear hurt? Usually, no. Expect pressure and some cramping when the speculum goes in, plus possible light spotting after. If you have ever had a speculum exam before, you know roughly what to expect.

Can I get one during my period? Ideally not, but you can. Mayo Clinic suggests avoiding it; the CDC says the tests can still be done. If heavy flow is the issue, reschedule for a few days later. If you cannot, go and mention it.

I have had only one partner. Do I really need it? Yes. Guidelines apply regardless of sexual history. HPV is extremely common and a single lifetime partner does not remove the risk.

I got the HPV vaccine. Am I exempt from screening? No, and this is explicit in the ACS guideline: vaccinated people follow the same screening schedule as unvaccinated people. The vaccine covers the main cancer-causing types, about 70 percent or more of cervical cancers, but not every oncogenic type.

I am past menopause. Do I still need screening? Yes. The CDC answers this one directly: if you no longer have periods, the age-based rules still apply. Past 65 with a clean history, you can stop. Before that, menopause changes nothing.

What does ASC-US on my report mean? It is the most common abnormal finding, and it means some cells look slightly off without a clear reason. Irritation, a yeast infection, a polyp, or hormonal shifts in pregnancy or menopause can all cause it. The usual next step is an HPV test, which sorts out whether follow-up is needed.

My report says the sample was unsatisfactory. Is something wrong? Not with you. It means the lab could not read the sample, too few cells, or cells hidden by blood or mucus. You repeat the test in two to four months. Liquid-based cytology makes this less likely than the conventional method.

How is a Pap smear different from an HPV test? The Pap looks at cells under a microscope for abnormal changes. The HPV test looks for the DNA of high-risk virus types in the sample. They answer different questions, which is why they are sometimes run together.

I had a hysterectomy. Do I still need screening? If your cervix was removed and there was no cervical cancer or high-grade precancer, no. If the cervix was kept, or there was a history of cancer or high-grade changes, screening continues. Your operative notes and your doctor settle this.

How often do I repeat it after a normal result? A normal result is called NILM, negative for intraepithelial lesion or malignancy, and it simply puts you back on the routine schedule: three years for Pap alone, five years if an HPV test was part of it.

Reading the result: the categories, decoded

Pap reports use a standard language called the Bethesda system. Learning it once means no report ever scares you blindly again. A typical report has three parts: a statement on whether the sample was adequate for reading, the epithelial cell result (the categories below), and, if an HPV test was ordered, its result appended at the bottom. Read it in that order, because the adequacy line decides whether the rest of the report even counts.

NILM is the normal result. No abnormal cells. Back to the routine schedule.

Unsatisfactory means the lab could not evaluate the sample. Repeat in two to four months. This is a lab problem, not a you problem.

ASC-US, atypical squamous cells of undetermined significance, is the most common abnormal result, and the least alarming. The cells look slightly off, and it is unclear whether HPV is involved. The standard next step is an HPV test: if it is negative, the changes are likely benign and you go back to routine or shorter-interval follow-up; if positive, more testing follows.

LSIL, low-grade squamous intraepithelial lesion, usually reflects an HPV infection. On biopsy this typically matches CIN1, the mildest grade of precancer, which usually goes away on its own and is generally not treated. Follow-up testing rules out anything more serious.

ASC-H means atypical cells that cannot rule out a high-grade lesion. That wording is enough to trigger a closer look, usually a colposcopy, where the cervix is examined under magnification.

HSIL, high-grade squamous intraepithelial lesion, means moderately to severely abnormal cells that could become cancer if left alone. This corresponds to CIN2, which is often treated and sometimes regresses, or CIN3, which is treated promptly except in pregnancy. Colposcopy comes first.

AGC, atypical glandular cells, involves the glandular cells higher inside the cervix and uterus. It can signal something more serious, so colposcopy is the standard response. A related, rarer finding is AIS, adenocarcinoma in situ, which is precancer of those glandular cells and is handled the way HSIL is: colposcopy and, usually, treatment.

Reading that list, the single most important sentence in the NCI's patient guidance is this: an abnormal result does not mean cancer, and most people with abnormal results do not have cancer. The modern follow-up framework, from the ASCCP's 2019 risk-based guidelines, does not treat these categories as one-size rules anyway. Your doctor weighs the current result against your history, prior results, and age, then chooses between repeat testing in one or three years, colposcopy with biopsy, or treatment. If treatment is needed for high-grade changes, it is usually a small outpatient procedure like LEEP or cryotherapy, not major surgery.

The HPV test that increasingly comes with it

Because one liquid-based vial can serve both tests, many labs now run the Pap and the HPV test from the same sample. That pairing is called co-testing. The newer idea, primary HPV screening, skips the Pap when the HPV test is negative and only brings cytology in when the HPV result is positive. The ACS now prefers that approach from age 25 onward.

Why is HPV testing skipped in the twenties? Because transient HPV infections are so common in young women that testing would mostly detect infections the immune system was about to clear on its own. That is the USPSTF's stated rationale. By 30, a persistent infection is more meaningful, which is when the HPV test earns its place.

If your doctor orders HPV genotyping, you will see type numbers on the report. Types 16 and 18 cause the majority of cervical cancers, and knowing the type helps the doctor decide how closely to watch you. It does not change the fact that most HPV infections, even with high-risk types, still resolve without treatment.

Do this, don't do that

The 48 hours before your appointment

Do: skip intercourse, douching, vaginal medicines, and spermicidal products for two full days, so the sample is clean and readable.

Don't: assume a ruined sample is rare. Blood, lubricant, or medicine residue is the most common reason a sample comes back unsatisfactory, which costs you a repeat visit.

At the lab

Do: tell the clinician about a latex allergy, blood thinners, any bleeding disorder, and the possibility of pregnancy before the exam begins.

Don't: brace for pain that usually never comes. It helps to say so plainly: most women describe pressure and brief cramping, not pain. Tensing up makes the speculum exam harder than it needs to be.

If your report says anything but NILM

Do: read the category, note what the plan says next, and keep the follow-up appointment. ASC-US and LSIL most often end with watchful follow-up, not treatment.

Don't: read an abnormal result as a cancer diagnosis. Most abnormal Pap results are not cancer, and the risk-based follow-up system exists precisely to sort the serious few from the self-resolving many.

If you are pregnant, vaccinated, or past menopause

Pregnancy does not cancel screening. A Pap can be done during pregnancy, and abnormal results in pregnancy are usually managed with observation rather than treatment, since the priority is the pregnancy. Pregnancy screening discussions often overlap with other first-trimester blood tests, and if you are in that phase, our guide to the NIPT test in pregnancy covers a different but related screening conversation worth reading.

Vaccination does not cancel screening either, as noted above, and India's free HPV vaccination drive for 14-year-old girls, launched in February 2026, is excellent news for the next generation without changing anything for women who are screening age today. The WHO's global elimination strategy aims for 90 percent of girls vaccinated, 70 percent of women screened twice in their lifetimes, and 90 percent of precancer treated, all by 2030. India is nowhere near the screening target yet, which is exactly why this article exists.

Menopause does not cancel screening, and neither does having had one child, or several, or none. No guideline ties screening to childbearing. The NHS makes the inverse point for the young: under-25s are not screened partly because unnecessary treatment could harm future pregnancies, which tells you how seriously overtreatment is taken.

One more group deserves a mention. Women living with HIV are about six times more likely to develop cervical cancer, and the WHO sets a tighter schedule for them: screening from age 25, every three to five years, with HPV DNA as the test. The same closer schedule applies to anyone immunosuppressed, for example after an organ transplant, and to women with a history of DES exposure or prior high-grade lesions. If any of that describes you, the routine intervals in this article do not apply, and your doctor will set a personal schedule.

Getting it done in Mumbai

The booking part is simple. The Pap smear with liquid-based cytology is the modern method, listed at ₹1,999 on the test page at the time of writing, and the conventional Pap smear is listed at ₹999 if your doctor is comfortable with the older slide method. When HPV testing is part of the plan, the HPV DNA detection and typing test and the simpler HPV DNA detection test are both available; the liquid-based Pap vial can serve both tests from one sample, which saves a second collection.

Because the sample needs a clinician visit, this is one of the few tests you cannot do at home, so book an in-lab slot. Our lab in Malad is open 24x7, reports typically land in about 24 hours, and you can book on 84250 40353. Bring your previous Pap or HPV reports if you have them; the prior result is part of how the doctor decides your follow-up. If you are due for broader screening anyway, the age-matched bundles are worth a look: the Women's Health Checkup for ages 30 to 45 and the Women's Health Checkup for ages 45 to 60 wrap cervical screening into wider panels, and the full packages page lists everything.

It is worth naming why so many women in Mumbai never get around to this. The reasons we hear are rarely medical. There is shyness about the exam, there is the assumption that no symptoms means no problem, there is the belief that one monogamous marriage removes the risk, and there is simple inertia. Cervical cancer's cruelty is that it rewards exactly that inertia: it gives you no symptoms while it is most curable. The screening stat, 1.9 percent, is not a fact about other women. It is a mirror.

A final word on who this is for. If you are a woman between 30 and 65 in Mumbai and you have never had a Pap smear, you are standing in the largest and most consequential gap in Indian women's health: 1.9 percent screened means almost everyone is unscreened, and the test you have been putting off is the one most likely to change your odds. Three years between tests, a few minutes in a clinic chair, pressure rather than pain, and a report you can now read. That is the whole of it.

So here is the short version to carry away. Screening catches precancer, and precancer takes years to turn, which is the entire game. Start at 25 under the American framework or 30 under India's programme, and ask your doctor which fits you. From 30, the menu is Pap alone, HPV test alone, or both together, every three or five years. The exam usually does not hurt, and two days of preparation keeps the sample readable. An abnormal result is not cancer; most abnormal results are not. Vaccination does not replace screening, and neither menopause nor a hysterectomy-with-cervix-kept ends the conversation. Pick a week, make the appointment, and join the two percent. The other 98 percent is not a place you want to be.

References

• American Cancer Society 2020 cervical cancer screening guideline (CA: A Cancer Journal for Clinicians)
• US Preventive Services Task Force: Cervical Cancer Screening recommendation (2018)
• WHO Guideline for screening and treatment of cervical pre-cancer lesions (2021)
• National Cancer Institute: Understanding Cervical Changes and abnormal Pap/HPV test results fact sheet